Volume 68, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


hyperinfection syndrome may be complicated by paralytic ileus that interferes with the absorption of oral anti-helminthics. We report on the administration of ivermectin as a rectal enema preparation to a renal transplant recipient with hyperinfection syndrome and progressive ileus. Attempts at treatment using nasogastric albendazole and ivermectin were unsuccessful despite clamping the nasogastric tube after drug administration. Ivermectin tablets were ground to a powder, resuspended in a commercially available suspending agent, and administered per rectum. The suspending agent was chosen for its near-physiologic osmolality to allow longer retention, in contrast to many enema preparations that have a laxative effect. The patient improved markedly within 72 hours of initiation of the therapy per rectum and recovered fully. Ivermectin administered as an enema may be beneficial in patients with severe strongyloidiasis who are unable to absorb or tolerate oral therapy.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB, 1981. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 3 : 397–407. [Google Scholar]
  2. Scowden EB, Schaffner W, Stone WJ, 1978. Overwhelming strongyloidiasis. An unappreciated opportunistic infection. Medicine (Baltimore) 57 : 527–544. [Google Scholar]
  3. Mahmoud AA, 1996. Strongyloidiasis. Clin Infect Dis 23 : 949–953. [Google Scholar]
  4. DeVault GA Jr, King JW, Rohr MS, Landreneau MD, Brown ST III, McDonald JC, 1990. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 12 : 653–657. [Google Scholar]
  5. Nonaka D, Takaki K, Tanaka M, Umeno M, Takeda T, Yoshida M, Haraguch Y, Okada K, Sawae Y, 1998. Paralytic ileus due to strongyloidiasis: case report and review of the literature. Am J Trop Med Hyg 59 : 535–538. [Google Scholar]
  6. Milner PF, Irvine RA, Barton CJ, Bras G, Richards R, 1965. Intestinal malabsorption in Strongyloides stercoralis infection. Gut 6 : 574–581. [Google Scholar]
  7. Cruz T, Reboucas G, Rocha H, 1966. Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med 275 : 1093–1096. [Google Scholar]
  8. Gann PH, Neva FA, Gam AA, 1994. A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. J Infect Dis 169 : 1076–1079. [Google Scholar]
  9. Marti H, Haji HJ, Savioli L, Chwaya HM, Mgeni AF, Ameir JS, Hatz C, 1996. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 55 : 477–481. [Google Scholar]
  10. Morgan JS, Schaffner W, Stone WJ, 1986. Opportunistic strongyloidiasis in renal transplant recipients. Transplantation 42 : 518–524. [Google Scholar]
  11. Berk SL, Verghese A, Alvarez S, Hall K, Smith B, 1987. Clinical and epidemiological features of strongyloidiasis. A prospective study in rural Tennessee. Arch Intern Med 147 : 1257–1261. [Google Scholar]
  12. Hoy WE, Roberts NJ, Bryson MF, Bowles C, Lee JCK, Rivero AJ, Ritterson AL, 1981. Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. JAMA 246 : 1937–1939. [Google Scholar]
  13. Palau LA, Pankey GA, 1997. Strongyloides hyperinfection in a renal transplant recipient receiving cyclosporine: possible Strongyloides stercoralis transmission by kidney transplant. Am J Trop Med Hyg 57 : 413–415. [Google Scholar]
  14. Nolan TJ, Schad GA, 1996. Tacrolimus allows autoinfective development of the parasitic nematode Strongyloides stercoralis. Transplantation 62 : 1038. [Google Scholar]
  15. Schad GA, 1986. Cyclosporin may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients. J Infect Dis 153 : 178. [Google Scholar]
  16. Archibald LK, Beeching NJ, Gill GV, Bailey JW, Bell Dr, 1993. Albendazole is effective treatment for chronic strongyloidiasis.Q J Med 86 : 191–195. [Google Scholar]
  17. Alvarez Chacon R, Rodriguez Rodriguez M, Cob Sosa CE, 1974. Evaluacion de la efectividad terapeutica del hexilresorcinol y del tiabendazol en la tricocefalosis masiva en ninos. Bol Med Hosp Infant Mex 31 : 1125–1147. [Google Scholar]
  18. Perez C, Menard E, Saelzer E, Atias A, 1977. Tricocefalosis infantil masiva: experiencia en 13 casos. Rev Med Chil 105 : 520–522. [Google Scholar]
  19. Kennedy S, Campbell RM, Lawrence JE, Nichol GM, Rao DM, 1989. A case of severe Strongyloides stercoralis infection with jejunal perforation in an Australian ex-prisoner of war. Med J Aust 150 : 92–93. [Google Scholar]
  20. Thomas MC, Costello SA, 1998. Disseminated strongyloidiasis arising from a single dose of dexamethasone before stereotactic radiosurgery. Int J Clin Pract 52 : 520–521. [Google Scholar]
  21. Boken DJ, Leoni PA, Preheim LC, 1993. Treatment of Strongyloides stercoralis hyperinfection syndrome with thiabendazole administered per rectum. Clin Infect Dis 16 : 123–126. [Google Scholar]
  22. Naquira C, Jimenez G, Guerra JG, Bernal R, Nalin DR, Neu D, Aziz M, 1989. Ivermectin for human strongyloidiasis and other intestinal helminths. Am J Trop Med Hyg 40 : 304–309. [Google Scholar]
  23. Costa JL, Diazgranados JA, 1994. Ivermectin for spasticity in spinal-cord injury (letter). Lancet 343 : 739. [Google Scholar]
  24. Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J, 2000. Parenteral ivermectin in Strongyloides hyperinfection (letter). Lancet 355 : 43–44. [Google Scholar]
  • Received : 20 Sep 2002
  • Accepted : 06 Nov 2002

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error